IRISanRaf

ROSANO, GIUSEPPE MASSIMO CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.643
AS - Asia 1.585
EU - Europa 527
SA - Sud America 221
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 3
Totale 4.002
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.517
SG - Singapore 631
CN - Cina 460
IT - Italia 283
TR - Turchia 279
BR - Brasile 186
CA - Canada 105
VN - Vietnam 97
DE - Germania 64
UA - Ucraina 43
HK - Hong Kong 33
GB - Regno Unito 30
IN - India 20
RU - Federazione Russa 19
MX - Messico 16
PL - Polonia 16
NL - Olanda 15
AR - Argentina 14
ID - Indonesia 14
JP - Giappone 12
EU - Europa 11
FR - Francia 11
SE - Svezia 11
IE - Irlanda 10
BD - Bangladesh 7
CO - Colombia 7
EC - Ecuador 7
ES - Italia 6
FI - Finlandia 6
IQ - Iraq 5
ZA - Sudafrica 5
KE - Kenya 4
PK - Pakistan 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
LB - Libano 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BG - Bulgaria 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
LT - Lituania 2
MY - Malesia 2
RO - Romania 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
VE - Venezuela 2
AM - Armenia 1
CH - Svizzera 1
CL - Cile 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HN - Honduras 1
JO - Giordania 1
LI - Liechtenstein 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 4.002
Salva come PNG Salva come JPEG
Città #
Dallas 369
Ashburn 198
Rome 198
Singapore 162
Santa Clara 154
San Mateo 147
Kocaeli 145
Beijing 117
Toronto 84
Houston 53
Shanghai 50
Chandler 44
Wilmington 41
Ho Chi Minh City 40
Frankfurt am Main 34
Hong Kong 33
São Paulo 30
Guangzhou 29
Lawrence 28
Los Angeles 28
Princeton 28
West Jordan 28
Hanoi 21
Warsaw 16
Boston 15
Council Bluffs 14
New York 14
Seattle 14
Munich 13
Tokyo 12
Assago 10
Chicago 10
Fairfield 10
Shenzhen 10
Atlanta 9
Brooklyn 9
Montreal 9
Milan 8
Stockholm 8
Wandsworth 8
Woodbridge 8
Boardman 6
Buffalo 6
Cambridge 6
Chennai 6
Manchester 6
Mexico City 6
San Francisco 6
The Dalles 6
Wuhan 6
Campinas 5
Charlotte 5
Cremona 5
Da Nang 5
Johannesburg 5
Phoenix 5
Rio de Janeiro 5
Rui'an 5
San Jose 5
Wuxi 5
Xi'an 5
Amsterdam 4
Dublin 4
Jakarta 4
Nairobi 4
Ottawa 4
Tashkent 4
Verona 4
Belo Horizonte 3
Brasília 3
Cassino 3
Curitiba 3
Denver 3
Haiphong 3
Helsinki 3
Jinhua 3
London 3
Medan 3
Nantong 3
New Delhi 3
Paris 3
Pune 3
Quito 3
Ribeirão Preto 3
São Gonçalo 3
Thái Bình 3
Turin 3
Turku 3
Andover 2
Aversa 2
Barbacena 2
Belford Roxo 2
Biên Hòa 2
Bogotá 2
Can Tho 2
Cariacica 2
Cincinnati 2
Cisterna di Latina 2
Ciudad del Este 2
Columbus 2
Totale 2.479
Salva come PNG Salva come JPEG
Nome #
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 119
Bisphosphonates and adipogenesis: Evidence for alendronate inhibition of adipocyte differentiation in 3T3-L1 preadipocytes through a vitamin D receptor mediated effect 71
MINERALCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CORTICOID-INDUCED OBESITY 69
Cellular Models for Understanding Adipogenesis, Adipose Dysfunction, and Obesity 65
Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure 63
Mineralocorticoid receptor in adipocytes and macrophages: A promising target to fight metabolic syndrome 59
Androgens and Adipose Tissue in Males: A Complex and Reciprocal Interplay 58
Essential role of ICAM-1 in aldosterone-induced atherosclerosis 57
Androgens and cardiovascular disease: gender-related differences 56
Tai chi enhances the effects of endurance training in the rehabilitation of elderly patients with chronic heart failure. 55
Erratum to: Comparison of Microlife BP A200 Plus and Omron M6 Blood Pressure Monitors to Detect Atrial Fibrillation in Hypertensive Patients 54
Anticoagulation in "real world" patients with atrial fibrillation in Italy: Results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study 53
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology 52
Endothelial effects of drugs designed to treat erectile dysfunction 50
The mineralocorticoid receptor in endothelial physiology and disease: novel concepts in the understanding of erectile dysfunction 50
Potential role of progestogens in the control of adipose tissue and salt sensitivity via interaction with the mineralocorticoid receptor 48
A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose 48
The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism 47
Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion 45
Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity 45
Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice 45
Exposure to Phosphodiesterase Type 5 Inhibitors Stimulates Aromatase Expression in Human Adipocytes in vitro 44
Mineralocorticoid vs glucocorticoid receptors: solo players or team mates in the control of adipogenesis? 44
International validation of the Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score in heart failure 44
Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs 43
Vitamin D: a novel player in endothelial function and dysfunction 43
On-target antihypertensive treatment in Italy: The ISPIT (Indagine Sicoa Paziente Iperteso a Target) survey study 43
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 43
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology 43
Phosphodiesterase type 5 (PDE5) in the adipocyte: a novel player in fat metabolism? 42
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib 39
Drug Layering in Heart Failure: Phenotype-Guided Initiation 38
Physical Training Reduces the Ability of Serum from Patients with Heart Failure to Induce Endothelial Cell Death 37
Effects of Nebivolol versus Carvedilol in Hypertensive Patients with Chronic Heart Failure 37
Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial). 37
Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance 36
Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure 36
ATP secreted by endothelial cells blocks CX₃CL 1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y₁₁ receptor activation 35
Effects of a short-term exercise training on serum factors involved in ventricular remodelling in chronic heart failure patients 35
Effect of exercise training on serum capacity to induce endothelial cell death in patients with chronic heart failure 34
Hydrotherapy added to endurance training versus endurance training alone in elderly patients with chronic heart failure: A randomized pilot study. 34
Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT 33
Trimetazidine improves exercise performance in patients with peripheral arterial disease 33
From glucose lowering to treatment of cardiovascular disease: the repositioning of glucose-lowering agents 33
Cardiac Metabolism in Myocardial Ischemia 32
Tricuspid annular plane systolic excursion is related to performance at six minute walking test in patients with heart failure undergoing exercise training. 32
CXCL12 prolongs naive CD4+ T lymphocytes survival via activation of PKA, CREB and Bcl2 and BclXl up-regulation 31
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology(ESC>) 31
Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients 30
COMPARISON BETWEEN INTERVAL TRAINING AND ENDURAND TRAINING ON 24-H BLOOD PRESSURE AND GLUCOSE METABOLISM IN HYPERTENSIVE PATIENTS WITH HEART FAILURE: A PILOT STUDY 30
Efficacy and safety of mineralocorticoid receptors in mild to moderate arterial hypertension. 30
MR antagonists protect against diet induced obesity and cardiac inflammation in mice, through browning of the adipose tissue and modulation of autophagy 30
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 29
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 29
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review 29
Anabolic hormonal response to different exercise training intensities in men with chronic heart failure 28
Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease. 27
Clinical utility of ivabradine in cardiovascular disease management: current status 27
Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. 27
Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes. A 27
Ranolazine 26
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology 26
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT 25
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 25
Atorvastatin attenuates post-implant tissue degeneration of cardiac prosthetic valve bovine pericardial tissue in a subcutaneous animal model. 25
Intensive cardiac rehabilitation improves glucometabolic state of non-diabetic patients with recent coronary artery bypass grafting 25
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 25
Menopause and cardiovascular disease: the evidence. Rosano GM, Vitale C, Marazzi G, Volterrani M 25
Corrigendum to "Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance" [Int. J. Cardiol. 202 (2016) 76-77] 24
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies 24
The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice 24
Dose-response relationship of baroreflex sensitivity and heart rate variability to individually-tailored exercise training in patients with heart failure 24
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 24
Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women. 23
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review- From the Optimal Nutraceutical Supplementation in Heart Failure (Onus-HF) Working Group. 23
Usefulness of Low-Dose Statin Plus Ezetimibe and/or Nutraceuticals in Patients With Coronary Artery Disease Intolerant to High-Dose Statin Treatment 23
Effect of High-Intensity interval training versus moderate continuous training on 24-h blood pressure profile and insulin resistance in patients with chronic heart failure. 23
Validation of rate of perceived exertion-based exercise training in patients with heart failure: Insights from autonomic nervous system adaptations. 22
Low testosterone levels are associated with coronary artery disease in male patients with angina. 22
Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease 22
Immunoregulation through extracellular nucleotides 22
Metabolic syndrome predicts lower functional recovery in female but not in male patients after an acute cardiac event. 22
Role of leucocyte count and thyroid-stimulating hormone in evolution of mild cognitive impairment to dementia 21
Comparison of Low-Dose Statin Versus Low-Dose Statin+Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial) 21
Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC 21
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 20
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT 20
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association and the European Heart Rhythm Association of the European Society of Cardiology and the the European Society of Hypertension 20
Modulating the metabolism by trimetazidine enhances myoblast differentiation and promotes myogenesis in cachectic tumor-bearing c26 mice 20
Ranolazine improves insulin resistance in non-diabetic patients with coronary heart disease. A pilot study. 20
Mineralocorticoid receptor in adipocytes and macrophages: a promising target to fight metabolic syndrome 20
Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity 20
Testosterone and heart failure. 19
Estrogen acutely increases peripheral blood flow in postmenopausal women. 19
Cytokines are not predictive of Alzheimer's disease in patients with mild cognitive impairment 19
Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome 19
The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubes 19
Practical Applications for Single Pill Combinations in the Cardiovascular Continuum 19
Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome. 19
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. 19
Totale 3.443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.559
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021230 0 0 0 0 0 22 15 8 12 9 148 16
2021/2022288 1 82 83 8 0 0 18 28 5 58 2 3
2022/2023245 61 1 3 14 11 17 0 13 9 93 19 4
2023/2024343 4 0 10 32 9 14 1 22 4 59 14 174
2024/20251.247 93 287 50 30 49 174 57 68 187 17 58 177
2025/20261.676 268 246 298 311 264 289 0 0 0 0 0 0
Totale 4.157